Article
Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606.
Molecular pharmacology - 1 Jun 2014
Oliver Kendra H, Jessen Tammy, Crawford Emily L, Chung Chang Y, Sutcliffe James S, Carneiro Ana M
Abstract excerpt
The plasma-membrane integrin αIIbβ3 (CD41/CD61, GPIIbIIIa) is a major functional receptor in platelets during clotting. A common isoform of integrin β3, Leu33Pro is associated with enhanced platelet function and increased risk for coronary thrombosis and stroke, although these findings remain controversial. To better understand the molecular mechanisms by which this sequence variation modifies platelet function,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
